The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global mother and child healthcare market reached a value of US$ 574.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,215.20 Billion by 2027, exhibiting at a CAGR of 12.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Mother and child healthcare (MCH) refers to medical services provided to children, adolescents and pregnant women. It includes birthing, fertility, child nutrition, prenatal and postnatal services. MCH emphasizes on preventive, curative, promotive and rehabilitative healthcare services that assist in promoting health, child nutrition and preventing medical ailments to reduce infant and maternal mortality. MCH aids in reducing morbidity and mortality due to unsafe abortions, levels of unwanted and unplanned pregnancies, female genital mutilation, risks of developing cervical cancer and enhancing reproductive health awareness among children. MCH also prevents malnutrition and infection among mothers and children and provides primary health care services.
Significant growth in the healthcare industry is one of the key factors creating a positive outlook for the market. MCH is widely adopted by parents to seek consultation from super-specialist doctors and ensure the good health of both mother and child. Additionally, the widespread adoption of MCH services by pregnant women due to insufficient or no availability of prenatal care and delivery without assistance from appropriately trained health care providers is favoring the market growth. Moreover, the development of various nutritional and micronutrient supplementation strategies that include zinc, calcium, iron and early prenatal food supplementation is providing a thrust to the market growth. These supplements provide essential nutrients in the required quantities and protect the mother and child from infections and diseases. In line with this, the easy availability of digitized claim processing and healthcare policy management solutions is positively impacting the market growth. Other factors, including the increasing number of women suffering from immunodeficiency virus and other chronic illnesses, along with the implementation of various government initiatives to improve public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mother and child healthcare market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on services, maternal age and location.
Breakup by Services:
Breakup by Maternal Age:
Breakup by Location:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ann & Robert Lurie Children's Hospital, Apollo Hospitals Enterprise Ltd., Arrowhead Regional Medical Center, Carle Foundation Hospital, ChristianaCare Christiana Hospital, Cincinnati Children's Hospital, Cleveland Clinic Institute, Cloudnine Group of Hospitals, King Faisal Specialist Hospital & Research Centre, Riley Hospital and The Jorvi Hospital.
|Base Year of the Analysis||2021|
|Segment Coverage||Services, Maternal Age, Location, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Ann & Robert Lurie Children's Hospital, Apollo Hospitals Enterprise Ltd., Arrowhead Regional Medical Center, Carle Foundation Hospital, ChristianaCare Christiana Hospital, Cincinnati Children's Hospital, Cleveland Clinic Institute, Cloudnine Group of Hospitals, King Faisal Specialist Hospital & Research Centre, Riley Hospital and The Jorvi Hospital.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at